Integer (NYSE:ITGR) Sees Large Volume Increase – Time to Buy?

Shares of Integer Holdings Co. (NYSE:ITGR) saw an uptick in trading volume on Monday . 225,325 shares traded hands during trading, a decline of 24% from the previous session’s volume of 296,848 shares.The stock last traded at $120.69 and had previously closed at $121.96.

Wall Street Analysts Forecast Growth

ITGR has been the topic of several research analyst reports. Oppenheimer lowered Integer from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st. Truist Financial increased their price target on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. KeyCorp lifted their target price on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Wells Fargo & Company reiterated an “overweight” rating and issued a $160.00 target price on shares of Integer in a research note on Tuesday, December 3rd. Finally, Citigroup increased their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. Two investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $147.67.

Integer Price Performance

The firm’s fifty day moving average is $135.47 and its 200 day moving average is $133.01. The company has a market capitalization of $4.08 billion, a P/E ratio of 36.12, a P/E/G ratio of 1.72 and a beta of 1.24. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The business had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. As a group, analysts predict that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Integer

Several large investors have recently made changes to their positions in the company. Mather Group LLC. raised its position in shares of Integer by 304.3% during the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 143 shares during the last quarter. Lee Danner & Bass Inc. acquired a new position in Integer in the fourth quarter valued at approximately $27,000. Huntington National Bank raised its holdings in Integer by 8,933.3% in the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 268 shares during the period. R Squared Ltd acquired a new position in shares of Integer in the 4th quarter worth approximately $44,000. Finally, Sterling Capital Management LLC grew its stake in shares of Integer by 472.9% in the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider’s stock valued at $45,000 after buying an additional 279 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.